Phreesia, Inc. Stock

Equities

PHR

US71944F1066

Software

Market Closed - Nyse 04:00:02 2024-04-23 pm EDT 5-day change 1st Jan Change
23.14 USD +3.26% Intraday chart for Phreesia, Inc. -0.09% -0.04%
Sales 2025 * 428M Sales 2026 * 507M Capitalization 1.3B
Net income 2025 * -92M Net income 2026 * -69M EV / Sales 2025 * 2.9 x
Net cash position 2025 * 65.84M Net cash position 2026 * 80.06M EV / Sales 2026 * 2.42 x
P/E ratio 2025 *
-13.9 x
P/E ratio 2026 *
-18.4 x
Employees 1,438
Yield 2025 *
-
Yield 2026 *
-
Free-Float 93%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.26%
1 week-0.09%
Current month-3.30%
1 month+0.56%
3 months-8.36%
6 months+59.48%
Current year-0.04%
More quotes
1 week
21.38
Extreme 21.38
23.68
1 month
21.38
Extreme 21.38
24.99
Current year
21.35
Extreme 21.35
29.16
1 year
12.05
Extreme 12.05
34.98
3 years
12.05
Extreme 12.05
76.10
5 years
12.05
Extreme 12.05
81.59
10 years
12.05
Extreme 12.05
81.59
More quotes
Managers TitleAgeSince
Founder 45 04-12-31
Founder 45 04-12-31
Director of Finance/CFO 50 19-06-30
Members of the board TitleAgeSince
Director/Board Member 71 07-09-30
Director/Board Member 53 19-04-30
Director/Board Member 56 20-07-19
More insiders
Date Price Change Volume
24-04-23 23.14 +3.26% 386,053
24-04-22 22.41 +3.27% 298,650
24-04-19 21.7 -4.07% 540,826
24-04-18 22.62 -2.33% 421,912
24-04-17 23.16 +0.70% 383,738

Delayed Quote Nyse, April 23, 2024 at 04:00 pm EDT

More quotes
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. The Company also provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
22.41 USD
Average target price
30.12 USD
Spread / Average Target
+34.43%
Consensus